METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA
Clinical trials for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat breast cancer: drug combo shows promise
Disease control CompletedThis study tested whether adding the drug veliparib to standard chemotherapy (cisplatin) helps people with a fast-growing type of breast cancer called triple-negative or BRCA-related breast cancer, including those whose cancer has spread to the brain. About 344 adults took part. …
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Old drug, new trick: bexarotene may Re-Sensitize resistant breast cancer
Knowledge-focused CompletedThis early study tested whether bexarotene, a drug already used for skin lymphoma, could make aggressive triple-negative breast cancer cells that stopped responding to taxane chemotherapy become sensitive again. 12 women with metastatic disease whose cancer had progressed after t…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Centre, Singapore • Aim: Knowledge-focused
Last updated May 17, 2026 03:00 UTC